Abstract:Recent studies have shown that Genistein can obviously suppress growth of gynecologic carcinoma. In this study we examined whether Genistein and Cisplatin, alone and in combination, exhibited a inhibitory effect on the growth of ovarian carcinoma. SKOV3 cells were treated with 20µM Genistein, 20µM Cisplatin and combination group (G+C) for 24 to 72 hours, antiproliferative effect was tested by MTT method. Apoptosis was evaluated using flow cytometry and transmission electron microscopy. Then the transplanted xenografts were treated with Genistein and Cisplatin, the tumor volume and tumor weight were measured, HE staining were performed for morphologic observation. A time and dose-dependent growth inhibition was observed. When treated the cells with 20µM Genistein, 20µMCisplatin and combination group (G+C), compared with the control group, the growth of cells in different treatment group was inhibited, while the combination of Genistein and Cisplatin showed significant inhibition effect than single agent. When Genistein (0.4mg/kg, s.c.) treated the transplanted xenograft in vivo, the tumor volume and tumor weight decreased, T/C ratio (mean volume of treated group/mean volume of control group) also was reduced compared to untreated group, and extensive necrotic areas in the tumor treated with Genistein and Cisplatin appeared in HE section. A weight loss of nude mice after treatment with Genistein was not significant as compared with the control group. And when treated with Genistein (0.4mg/kg, s.c.) and Cisplatin (4mg/kg, i.v.), it showed a synergistic effect. Genistein and Cisplatin, alone and in combination, suppress cell growth. The combination of Genistein and Cisplatin, as compared to single treated group, caused a synergistic increase in antiproliferative effect on SKOV3 cells. The implication for treatment of ovarian cancer may be combination of Genistein and Cisplatin. Further studies are needed to supply more evidence.

Genistein reinforces the inhibitory effect of Cisplatin on liver cancer recurrence and metastasis after curative hepatectomy.

Effect of genistein and cisplatin on recrrence and metastasis of hepatocellular cardnoma after curative resection in athymic mice

Effect of Alarelin Combined with Cisplatin on Subcutaneous Xenograft of Human Endometrial Carcinoma in Nude Mice

Genistein Interferes with Antitumor Effects of Cisplatin in an Ovariectomized Breast Cancer Xenograft Tumor Model.

Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma.

Genistein Modulates the Anti-Tumor Activity of Cisplatin in MCF-7 Breast and HT-29 Colon Cancer Cells

Genistein and Cisplatin, Alone and in Combination, Suppress Growth of Human Ovarian Carcinoma Cell Line SKOV3

The Phytoestrogen Genistein Inhibits the Anti-Tumor Activity of Cisplatin in MCF-7 Breast and HT29 Colon Cancer Cells

Genistein Inhibits Invasive Potential of Human Hepatocellular Carcinoma by Altering Cell Cycle, Apoptosis, and Angiogenesis

Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Genistein Enhances Radiosensitivity of Human Hepatocellular Carcinoma Cells by Inducing G2/M Arrest and Apoptosis.

Influence of Genistein on the Invasive and Metastatic Ability of Hepatoma Cells

Inhibitory Effects of Genistein on Metastasis of Human Hepatocellular Carcinoma.

Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.

Effects of Genistein on the Growth of Human Ovarian Carcinoma Transplanted Subcutaneously in Nude Mice

Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death

Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro

Effect of genistein on tumor recurrence and metastasis of hepatocellular carcinoma after curative resection in athymic mice

Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.

Effects of Genistein on biological behavior of human hepatocarcinoma cells in vitro